Committee for Medicinal Products for Human Use - PDFSEARCH.IO - Document Search Engine

Committee for Medicinal Products for Human Use
Results: 188

#	Item
51	Guideline on the use of starting materials-intermediates collected from different sources in the manufacturing of biological medicinal products - for publishing Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:43:56 Pharmaceuticals policy Pharmaceutics Pharmacology Clinical research Biologic European Medicines Agency Marketing authorization Committee for Medicinal Products for Human Use Good manufacturing practice Pharmaceutical industry Business Pharmaceutical sciences
52	Regulatory acceptance of 3Rs testing methods for medicinal products – EMA perspective Dr. Sonja Beken EMA Joint Expert Group on the application of 3Rs EMA Safety Working Party Add to Reading List Source URL: circabc.europa.eu Language: English Pharmaceutical sciences Pharmaceutics European Medicines Agency EMA Validation European Directorate for the Quality of Medicines Committee for Medicinal Products for Human Use Clinical trial Clinical research Pharmaceutical industry Research
53	Microsoft Word - CTS227355798 Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 05:37:31 Biological weapons Piperazines Microbiology Occupational diseases Zoonoses Anthrax Doxycycline Committee for Medicinal Products for Human Use Pefloxacin Medicine Health Biology
54	CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Revision 4, June 2010 Add to Reading List Source URL: www.hma.eu Language: English - Date: 2013-08-01 09:55:16 Research Pharmaceutical sciences Health European Union Medicinal product Committee for Medicinal Products for Human Use Summary of Product Characteristics Referral marketing Directive 2001/83/EC Clinical research Pharmacology Pharmaceuticals policy
55	CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Rev. 5, July 2013 Add to Reading List Source URL: www.hma.eu Language: English - Date: 2013-08-01 10:03:34 Research Pharmaceutical sciences Health European Union Committee for Medicinal Products for Human Use Directive 2001/83/EC Summary of Product Characteristics Medicinal product Biosimilar Clinical research Pharmaceuticals policy Pharmacology
56	achanA April 27, 2007 Astellas Receives an European Commission Approval for Advagraf Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:27:09 Health Pharmacology Macrolides Tacrolimus Astellas Pharma European Medicines Agency Immunosuppressive drug Transplant rejection Committee for Medicinal Products for Human Use Medicine Pharmaceutical industry Immunosuppressants
57	Microsoft Word - PtC_Biological-for public consultation-HMPWG Add to Reading List Source URL: www.hma.eu Language: English - Date: 2014-12-24 05:41:23 Whole medical systems Pseudoscience Homeopathy Clinical research Pharmaceutical industry Biologic Cell culture Committee for Medicinal Products for Human Use Alternative medicine Biology Medicine Health
58	Report from the CMDh meeting held on 16th, 17th and 18th July 2012 Impact of the implementation of the new pharmacovigilance legislation (Regulation (EU) No[removed]and Directive[removed]EU) on Marketing Authorisations Add to Reading List Source URL: www.hma.eu Language: English - Date: 2012-07-26 10:37:53 Computing Pascal Committee for Medicinal Products for Human Use Programming language theory
59	Report from the CMDh meeting held on 16th, 17th and 18th January 2012 Topiramate and risk of congenital malformations The CMDh has endorsed the PhVWP report on topiramate and the risk of congenital malformations and reco Add to Reading List Source URL: www.hma.eu Language: English - Date: 2012-01-27 11:54:38
60	Report from the CMDh meeting held on 14th, 15th and 16th January 2013 Implementation of the new pharmacovigilance legislation (Regulation (EU) No[removed]and Directive[removed]EU) The CMDh recommends marketing authoris Add to Reading List Source URL: www.hma.eu Language: English - Date: 2013-01-23 09:55:20

UPDATE